REYKJAVÍK, Iceland, Aug. 28, 2024 /PRNewswire/ -- A new study conducted by an international team of researchers has unveiled a...
Formedics—home to flagships Physician's Weekly, Figure 1, and OncWeekly—grows reach by more than 60% to 1.5 million opted-in physicians, nurse...
Vancouver, British Columbia and Rehovot, Israel--(Newsfile Corp. - August 28, 2024) - BioHarvest Sciences Inc. (CSE: BHSC) (OTCQB: CNVCF) ("BioHarvest" or...
Nuvay™ Pressure-Redistributing Foam Mattresses Designed to Help Patients Rest, Heal During Hospital StaysHOUSTON, TX / ACCESSWIRE / August 28, 2024...
COCONUT CREEK, FL / ACCESSWIRE / August 28, 2024 / New Wave Endo-Surgical Corp. announced that it has been named...
Sachs Center is proud to announce the launch of its groundbreaking AI tool, designed specifically to support neurodivergent adults.NEW YORK,...
TORONTO, ON / ACCESSWIRE / August 28, 2024 / Theralase® Technologies Inc. ("Theralase®" or the "Company") (TSXV:TLT)(OTCQB:TLTFF), a clinical stage...
Correction of sign on three values in the Changes in working capital on page 16 of the report. Corrected values...
BOULDER, CO / ACCESSWIRE / August 28, 2024 / Sonoma Pharmaceuticals, Inc. (NASDAQ:SNOA), a global healthcare leader developing and producing...
NEW YORK and VIENNA, Aug. 28, 2024 (GLOBE NEWSWIRE) -- HOOKIPA Pharma Inc. (NASDAQ: HOOK, “HOOKIPA”, the “Company”), a company...
SciSparc would be entitled to receive consideration valued at $3 million in Polyrizon securities, as well as potential milestone fees...
Company’s Second Distribution Agreement in Middle EastWINNIPEG, Manitoba, Aug. 28, 2024 (GLOBE NEWSWIRE) -- Kane Biotech Inc. (TSX- V:KNE; OTCQB:KNBIF)...
NOT FOR DISTRIBUTION TO THE U.S. NEWS WIRE SERVICES OR DISSEMINATION IN THE UNITED STATESMARKHAM, Ontario, Aug. 28, 2024 (GLOBE...
TORONTO and HAIFA, Israel, Aug. 28, 2024 (GLOBE NEWSWIRE) -- NurExone Biologic Inc. (TSXV: NRX) (OTCQB: NRXBF) (Germany: J90) (the...
DOYLESTOWN, Pa., Aug. 28, 2024 (GLOBE NEWSWIRE) -- Aprea Therapeutics, Inc. (Nasdaq: APRE) (“Aprea” or the “Company”), a clinical stage...
COPENHAGEN, Denmark, Aug. 28, 2024 (GLOBE NEWSWIRE) -- Ascendis Pharma A/S (Nasdaq: ASND) today announced it will report second quarter...
R&D Discussion in New York City to Review IL-12’s Potential to Treat Ovarian Cancer Program Features Ovarian Cancer Thought Leaders,...
Mestag Therapeutics Employees of Cambridge, UK based Mestag Therapeutics - Innovate UK, part of UK Research and Innovation, is investing...
NEW YORK, Aug. 28, 2024 (GLOBE NEWSWIRE) -- Intra-Cellular Therapies, Inc. (Nasdaq: ITCI), a biopharmaceutical company focused on the development...
ORANGE, Calif., Aug. 28, 2024 (GLOBE NEWSWIRE) -- Alignment Healthcare, Inc. (NASDAQ: ALHC), today announced that John Kao, founder and...